Cargando…
Can postoperative complications be reduced by the application of ERAS protocols in operated non-small cell lung cancer patients?
BACKGROUND: In our study, we aimed to evaluate the length of hospital stay and complication rate of patients before and after application o f t he E nhanced R ecovery A fter S urgery ( ERAS) protocols. METHODS: Between January 2001 and January 2021, a total of 845 patients (687 males, 158 females; m...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bayçınar Medical Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357847/ https://www.ncbi.nlm.nih.gov/pubmed/37484631 http://dx.doi.org/10.5606/tgkdc.dergisi.2023.23514 |
_version_ | 1785075583649054720 |
---|---|
author | Turna, Akif Özçıbık Işık, Gizem Ekinci Fidan, Merve Sarbay, İsmail Kılıç, Burcu Kara, Hasan Volkan Erşen, Ezel Kaynak, Mehmet Kamil |
author_facet | Turna, Akif Özçıbık Işık, Gizem Ekinci Fidan, Merve Sarbay, İsmail Kılıç, Burcu Kara, Hasan Volkan Erşen, Ezel Kaynak, Mehmet Kamil |
author_sort | Turna, Akif |
collection | PubMed |
description | BACKGROUND: In our study, we aimed to evaluate the length of hospital stay and complication rate of patients before and after application o f t he E nhanced R ecovery A fter S urgery ( ERAS) protocols. METHODS: Between January 2001 and January 2021, a total of 845 patients (687 males, 158 females; mean age: 55±11 years; range, 19 to 89 years) who were operated with the diagnosis of non-small cell lung carcinoma were retrospectively analyzed. The patients were divided into three groups as follows: patients between 2001 and 2010 were evaluated as pre-ERAS (Group 1, n=285), patients between 2011 and 2015 as preparation for ERAS period (Group 2, n=269), and patients who had resection between 2016 and 2021 as the ERAS period (Group 3, n=291). RESULTS: All three groups were similar in terms of clinical, surgical and demographic characteristics. Smoking history was statistically significantly less in Group 3 (p=0.005). The forced expiratory volume in 1 sec/forced vital capacity and albumin levels were statistically significantly higher in Group 3 (p<0.001 and p=0.019, respectively). The leukocyte count and tumor maximum standardized uptake value were statistically significantly higher in Group 1 (p=0.018 and p=0.014, respectively). Postoperative hospitalization day, complication rate, and intensive care hospitalization rates were statistically significantly lower in Group 3 (p<0.001). The rate of additional disease was statistically significantly higher in Group 1 (p=0.030). Albumin level (<2.8 g/dL), lymphocyte/monocyte ratio (<1.35), and hemoglobin level (<8.3 g/dL) were found to be significant predictors of complication development. CONCLUSION: With the application of ERAS protocols, length of postoperative hospital stay, complication rate, and the need for intensive care hospitalization decrease. Preoperative hemoglobin level, albumin level, and lymphocyte/monocyte ratio are the predictors of complication development. Increasing hemoglobin and albumin levels before operation may reduce postoperative complications. |
format | Online Article Text |
id | pubmed-10357847 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Bayçınar Medical Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-103578472023-07-21 Can postoperative complications be reduced by the application of ERAS protocols in operated non-small cell lung cancer patients? Turna, Akif Özçıbık Işık, Gizem Ekinci Fidan, Merve Sarbay, İsmail Kılıç, Burcu Kara, Hasan Volkan Erşen, Ezel Kaynak, Mehmet Kamil Turk Gogus Kalp Damar Cerrahisi Derg Original Article BACKGROUND: In our study, we aimed to evaluate the length of hospital stay and complication rate of patients before and after application o f t he E nhanced R ecovery A fter S urgery ( ERAS) protocols. METHODS: Between January 2001 and January 2021, a total of 845 patients (687 males, 158 females; mean age: 55±11 years; range, 19 to 89 years) who were operated with the diagnosis of non-small cell lung carcinoma were retrospectively analyzed. The patients were divided into three groups as follows: patients between 2001 and 2010 were evaluated as pre-ERAS (Group 1, n=285), patients between 2011 and 2015 as preparation for ERAS period (Group 2, n=269), and patients who had resection between 2016 and 2021 as the ERAS period (Group 3, n=291). RESULTS: All three groups were similar in terms of clinical, surgical and demographic characteristics. Smoking history was statistically significantly less in Group 3 (p=0.005). The forced expiratory volume in 1 sec/forced vital capacity and albumin levels were statistically significantly higher in Group 3 (p<0.001 and p=0.019, respectively). The leukocyte count and tumor maximum standardized uptake value were statistically significantly higher in Group 1 (p=0.018 and p=0.014, respectively). Postoperative hospitalization day, complication rate, and intensive care hospitalization rates were statistically significantly lower in Group 3 (p<0.001). The rate of additional disease was statistically significantly higher in Group 1 (p=0.030). Albumin level (<2.8 g/dL), lymphocyte/monocyte ratio (<1.35), and hemoglobin level (<8.3 g/dL) were found to be significant predictors of complication development. CONCLUSION: With the application of ERAS protocols, length of postoperative hospital stay, complication rate, and the need for intensive care hospitalization decrease. Preoperative hemoglobin level, albumin level, and lymphocyte/monocyte ratio are the predictors of complication development. Increasing hemoglobin and albumin levels before operation may reduce postoperative complications. Bayçınar Medical Publishing 2023-04-28 /pmc/articles/PMC10357847/ /pubmed/37484631 http://dx.doi.org/10.5606/tgkdc.dergisi.2023.23514 Text en Copyright © 2023, Turkish Society of Cardiovascular Surgery https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Article Turna, Akif Özçıbık Işık, Gizem Ekinci Fidan, Merve Sarbay, İsmail Kılıç, Burcu Kara, Hasan Volkan Erşen, Ezel Kaynak, Mehmet Kamil Can postoperative complications be reduced by the application of ERAS protocols in operated non-small cell lung cancer patients? |
title | Can postoperative complications be reduced by the application of ERAS protocols in operated non-small cell lung cancer patients? |
title_full | Can postoperative complications be reduced by the application of ERAS protocols in operated non-small cell lung cancer patients? |
title_fullStr | Can postoperative complications be reduced by the application of ERAS protocols in operated non-small cell lung cancer patients? |
title_full_unstemmed | Can postoperative complications be reduced by the application of ERAS protocols in operated non-small cell lung cancer patients? |
title_short | Can postoperative complications be reduced by the application of ERAS protocols in operated non-small cell lung cancer patients? |
title_sort | can postoperative complications be reduced by the application of eras protocols in operated non-small cell lung cancer patients? |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357847/ https://www.ncbi.nlm.nih.gov/pubmed/37484631 http://dx.doi.org/10.5606/tgkdc.dergisi.2023.23514 |
work_keys_str_mv | AT turnaakif canpostoperativecomplicationsbereducedbytheapplicationoferasprotocolsinoperatednonsmallcelllungcancerpatients AT ozcıbıkisıkgizem canpostoperativecomplicationsbereducedbytheapplicationoferasprotocolsinoperatednonsmallcelllungcancerpatients AT ekincifidanmerve canpostoperativecomplicationsbereducedbytheapplicationoferasprotocolsinoperatednonsmallcelllungcancerpatients AT sarbayismail canpostoperativecomplicationsbereducedbytheapplicationoferasprotocolsinoperatednonsmallcelllungcancerpatients AT kılıcburcu canpostoperativecomplicationsbereducedbytheapplicationoferasprotocolsinoperatednonsmallcelllungcancerpatients AT karahasanvolkan canpostoperativecomplicationsbereducedbytheapplicationoferasprotocolsinoperatednonsmallcelllungcancerpatients AT ersenezel canpostoperativecomplicationsbereducedbytheapplicationoferasprotocolsinoperatednonsmallcelllungcancerpatients AT kaynakmehmetkamil canpostoperativecomplicationsbereducedbytheapplicationoferasprotocolsinoperatednonsmallcelllungcancerpatients |